Technology · 26 views
Allen Institute’s big new bet: $200M effort aims to go from mapping the brain to treating disease
The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS.
Summary
The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS. It marks the first time the Seattle research organization, founded by Paul Allen in 2003, has made treating disease its goal.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Technology
Continue reading recent Technology coverage
- What's the biggest IMAX theater in the world? It depends who you askContinue reading
- Volkswagen’s slippery new EV breaks a bunch of efficiency recordsContinue reading
- Phone makers ditched 3.5mm for USB-C, but which one offers better audio quality?Continue reading
- Microsoft floats rules for its own AI models as industry debates a slowdownContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow